P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors

Current Eye Research

Volumn 16, Issue 12, 1997, Pages 1179-1192

  Dushku, Nicholas ^a   Reid, Ted W ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

Limbal tumors; p53; Pingueculae; Pterygia

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53; VIMENTIN;

ARTICLE; BASAL CELL; CELL DEATH; CELL TYPE; CLASSIFICATION; CONJUNCTIVA TUMOR; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOGENESIS; PINGUECULA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; RECURRENT DISEASE; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

EID: 0030721608     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.16.12.1179.5036     Document Type: Article

References (88)

1. Dushku, N., Tyler, N. and Reid, T. W. (1993) Immunohistochemical evidence that pterygia arise from altered limbal epithelial basal stem cells. (Abstract). Invest. Ophthalmol. Vis. Sci. 34 (Suppl.), 1013.
2. Dushku, N. and Reid, T. W. (1994) Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr. Eye Res. 13b, 473-481.
3. Spencer, W. H. (1985) Ophthalmic Pathology: An Atlas and Textbook. 3rd ed. P. 304. Saunders, Philadelphia, PA.
4. Reese, A. B. (1976) Tumors of the Eye. 3rd ed. Pp. 53-55. Harper & Row, New York.
5. Duke-Elder, S. (1965) Diseases of the outer eye. In System of Ophthalmology, Vol. 8 (Ed. Duke-Elder, S.). Pp. 573-582. C.V. Mosby, St. Louis, MO, USA.
6. Cha, S. B., Shields, J. A., Shields, C. L. and Wang, M. X. (1993) Squamous cell carcinoma of the conjunctiva. In International Ophthalmology Clinics, Vol. 33, No. 3 (Ed. Shields, J. A). Pp. 19-24. Little, Brown and Company, Boston.
7. Tabbara, K. F., Kersten, R., Daquk, N. and Blodi, F. C. (1988) Metastatic squamous cell carcinoma. Ophthalmology, 95, 318-321.
8. Schermer, A., Galvin, S. and Sun, T. T. (1986) Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J. Cell Biol. 103, 49-62.
9. Lavker, R. M., Dong, G., Cheng, S. Z., Kudoh, K., Costarelis, G. and Sun, T. T. (1991) Relative proliferative rates of limbal and corneal epithelial implications of corneal epithelial migration, circadian rhythm, and suprabasally-located DNA-synthesizing keratinocytes. Invest. Ophthalmol. Vis. Sci. 32, 1864-1875.
10. Wei, Z.-G., Wu, R.-L., Lavker, R. M. and Sun, T.-T. (1993) In vitro growth and differentiation of rabbit bulbar, fornix, and palpebral conjunctival epithelia. Implications on conjunctival epithelial transdifferentiation and stem cells. Invest. Ophthalmol. Vis. Sci. 34, 1814-1828.
11. Hogan, M. J. and Zimmerman, L. E. (1962) Ophthalmic Pathology: An Atlas and Textbook. 2nd ed. Pp. 253-254. Saunders, Philadelphia, PA, USA.
12. Cameron, M. (1965) Pterygium Throughout the World. P. 125. Charles C. Thomas, Springfield, IL, USA.
13. Kenyon, K. R., Fogle, J. A. and Grayson, M. (1991) Dysgeneses, dystrophies and degenerations of the cornea. In Duane's Clinical Ophthalmology (Eds. Tasman, W. and Jaeger, E. A.). Pp. 1-49. Lippincott, Philadelphia, PA.
14. Yanoff, M. and Fine, B. S. (1982) Ocular Pathology, 2nd ed. P. 332. Harper & Row, Philadelphia, PA.
15. Cameron, M. E. (1962) Geographic distribution of pterygia. Trans. Ophthalmol. Soc. Aust. 22, 67-81.
16. Taylor, H. R., West, S. K., Rosenthal, F. S., Munoz, B. M., Newland, H. S. and Emmett, E. A. (1989) Corneal changes associated with chronic UV irradiation. Arch. Ophthalmol. 107, 1481-1484.
17. Clear, A. S., Chirambo, M. C. and Hutt, M. S. R. (1979) Solar keratosis, pterygium, and squamous cell carcinoma of the conjunctiva in Malawi. Br. J. Ophthalmol. 63, 102-109.
18. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J. and Ponten, J. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88, 10124-10128.
19. Kress, S., Sutter, C., Strickland, P. T., Mukhtar, H., Schweizer, J. and Schwartz, M. (1992) Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 52, 6400-6403.
20. Vogelstein, B. and Kinzler, K. W. (1992) Carcinogens leave fingerprints. Nature, 355, 209-210.
21. Ziegler, A., Leffell, D. J., Kunala, S., Sharma, H. W., Gailani, M., Simon, J. A., Halperin, A. J. and Baden, H. P. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl. Acad. Sci. USA, 90, 4216-4220.
22. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. (1991) P53 mutations in human cancers. Science, 253, 49-53.
23. Harris, A. L. (1990) Mutant p53 - the commonest genetic abnormality in human cancer? J. Pathol. 162, 5-6.
24. Lane, D. (1993) A death in the life of p53. Nature, 362, 786-787.
25. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A. and Jacks, T. (1993) P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
26. Clarke, A. R., Purdle, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L. and Wyllie, A. H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
27. Fritsche, M., Haessler, C. and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
28. McBride, O. W., Merry, D. and Givol, D. (1986) The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17 p 13). Proc. Natl. Acad. Sci. USA, 83, 130-134.
29. Levine, A. J. (1993) The tumor suppressor genes. Ann. Rev. Biochem. 62, 623-651.
30. Marx, J. (1993) How p53 suppresses cell growth. Science, 262, 1644-1645.
31. Harper, J. W., Adami, G. R., Wei, N., Keyomarai, K. and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
32. El-Deiry, W. S., Tokino, T., Velcuescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D. and Mercer, W. E. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-826.
33. Kinzler, K. W. and Vogelstein, B. (1996) Life (and death) in a malignant tumour. Nature, 379, 19-20.
34. Levine, A. J., Finaly, C. A. and Hinds, P. W. (1989) The p53 proto-oncogene and its product. In Common Mechanisms of Transformation by Small DNA Tumor Viruses, (Ed. Villareal, L. P.). Pp. 21-37. American Society for Microbiology, Washington, D.C.
35. Dippold, W. G., Jay, G., DeLeo, A. B., Khoury, G. and Old, L. J. (1981) P53 transformation-related proteins: detection by monoclonal antibody in mouse and human cells. Cell Biology, 78, 1695-1699.
36. Crawford, L. V., Pim, D. C., Gurney, E. G., Goodfellow, P. and Papadimitriou, J. T. (1981) Detection of a common feature in several human tumor cell lines: a 53,000-dalton protein. Proc. Natl. Acad. Sci. USA, 78, 41-45.
37. Benchimol, S., Pim, D. and Crawford, L. (1982) Radioimmunoassay of cellular protein p53 in mouse and human cell lines. EMBO J. 1, 1055-1062.
38. Iggo, R., Gatter, K., Bartek, I., Lane, D. and Harris, A. L. (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335, 675-679.
39. Lane, D. P. and Benchmol, S. (1990) P53: oncogene or anti-oncogene. Genes Dev. 4, 1-8.
40. Bartek, J., Bartkaova, J., Vojesek, B., et al. (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene, 6, 1699-1703.
41. Dushku, N. and Reid, T. W. (1994) Immunohistochemical evidence that pterygia originate from P53 expressing transformed limbal epithelial basal stem cells. (Abstract). Invest. Ophthalmol. Vis. Sci. 35 (Suppl.), S1796.
42. Cho, Y., Gorina, S., Jeffrey, P. D. and Pavletich, N. P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355.
43. Lane, D. P., Midgley, C. and Hupp, T. (1993) Tumor suppressor genes and molecular chaperones. Phil. Trans. R. Soc. Lond. 339, 369-373.
44. Levine, A. J. (1993) 11th Ernst Klenk Lecture. The p53 tumor suppressor. Biological Chem. 374, 227-235.
45. Finley, C. A., Hinds, P. W. and Levine, A. J. (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093.
46. Bartek, J., Iggo, R. and Gannon, J. (1990) Genetic and immunochemical analysis of mutant p53. Oncogene, 5, 893-899.
47. Moll, U. M., Riou, G. and Levine, A. J. (1992) Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA, 89, 7262-7266.
48. Vojtesek, B., Bartek, J., Midgley, C. A. and Lane, D. P. (1992) An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immun. Meth. 151, 237-244.
49. van den Berg, F. M., Baas, I. O., Polak, M. M. and Offerhaus, G. J. A. (1992) Detection of novel target unmasking fluid. Am. J. Pathol. 142, 381-385.
50. Man, Y-G. and Tavassoli, F. A. (1996) A simple epitope retrieval method without the use of microwave oven or enzyme digestion. Appl. Immunohistochem. 4, 139-141.
51. Taylor, C. R., Shi, S.-R., Chaiwun, S., Young, L., Imam, S. A. and Cote, R. J. (1994) Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum. Pathol. 25, 263-270.
52. Lovelace C, Zhang J, Vanek P, Collier G. (1996) Detecting apoptotic cells in situ. Biomedical Products, 21, 76-11.
53. Hogan, M. J., Alvarado, J. and Weddell, J. E. (1971) Histology of the Human Eye. P. 133. W.B. Saunders, Philadelphia, PA.
54. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Remington, L., Jacks, T. and Brash, D. E. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.
55. Blum, H. F. (1959) Carcinogenesis by ultraviolet light. Princeton University Press, Princeton, NJ., USA.
56. Buschke, W., Friedenwald, J. S. and Moses, S. G. (1945) Effects of ultraviolet irradiation on corneal epithelium: mitosis, nuclear fragmentation, post-traumatic cell movements, loss of tissue cohesion. J. Cell Comp. Physiol. 26, 147-164.
57. Duke-Elder, S. (1965) Nonmechanical injuries. In System of Ophthalmology, Vol 14, Part 2 (Ed. Duke-Elder, S.). Pp. 912-927. C.V. Mosby, St. Louis, MO, USA.
58. Wang, I.-J., Hu, F.-R. and Lin, C.-T. (1996) Apoptosis in pterygium tissue. Invest. Ophthal. Vis. Sci. 37 (Suppl.), 359.
59. Jaros, P. A. and DeLuise, V. P. (1988) Pingueculae and pterygia. Surv. Ophthalmol. 33, 41-49.
60. Austin, P., Jakobiec, F. A. and Iwamoto, T. (1983) Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology, 90, 96-109.
61. Li, Z.-Y., Wallace, R. N., Streeten, B. W., Kuntz, B. L. and Dark, A. J. (1991) Elastic fiber components and protease inhibitors in pinguecula. Invest. Ophthalmol. Vis. Sci. 32, 1573-1585.
62. Dake, Y., Mukae, R., Soda, Y., Kaneko, M. and Amemiya, T. (1989) Immunohistochemical localization of collagen types I, II, III, and IV in pterygium tissues. Acta Histochemica, 87, 71-74.
63. Imayama, S., Nakamura, K., Takeuchi, M., Hori, Y., Takema, Y., Sakaino, Y and Imokawa, G. (1994) Ultraviolet-B irradiation deforms the configuration of elastic fibers during the induction of actinic elastosis in rats. J. Dermatological Sci. 7, 32-38.
64. Pravata, G., Noto, G. and Arico, M. (1994) Increased SS bonds in chronic solar elastosis: a study with N-(7-dimethylamino-4-methyl-3-coumarinyl) maleimide (DACM) stain. J. Dermatological Sci. 7, 14-23.
65. Kligman, L. H. (1986) Photoaging: manifestations, prevention and treatment. Dermatologic Clinics, 4, 517-528.
66. Fazio, M. J., Mattei, M.-G., Passage, E., Chu, M. L., Black, D., Solomon, E., Davidson, J. M. and Vitto, J. (1991) Human elastin gene: new evidence for localization to the long arm of chromosome 7. Am. J. Hum. Genet. 48, 696-703.
67. Bernstein, E. F., Chen, Y Q., Tamai, K., Shepley, K. J., Resnik, K. S., Zhang, H., Tuan, R., Mauviel, A. and Vitto, J. (1994) Enhanced elastin and fibrillin gene expression in chronically photodamaged skin. J. Invest. Dermatol. 103, 182-186.
68. Kossard, S., Anderson, P., Davies, A. and Cooper, A. (1993) Histological evaluation of the effect of 0.05% tretinoin in the treatment of photo damaged skin. Australas J. Dermatol. 34, 89-95.
69. Duke-Elder, S. (1965) Diseases of the outer eye. In System of Ophthalmology, Vol 8 (Ed. Duke-Elder, S.). Pp. 570-582. C.V. Mosby, St. Louis, MO.
70. Sugar, S. and Kobernick, S. (1959) The pinguecula. Am. J. Ophthalmol. 47, 341-345.
71. Shaulsky, G., Goldfinger, N., Tosky, M. S., Levine, A. J. and Rotter, V. (1991) Nuclear localization is essential for the activity of p53 protein. Oncogene, 6, 2055-2065.
72. Dameron, K. M., Volpert, O. V., Tainsky, A. and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582-1584.
73. Dushku, N. and Reid, T. W. (1995) Immunohistochemical evidence that pterygia originate from Rb and TGFβ-expressing, p53-transformed, limbal basal stem cells. (Abstract). Invest. Ophthalmol. Vis. Sci. 36, S1027.
74. Tseng, S., Merritt, J., Ding, F. and Li, D. (1993) Mechanism of the TGF-beta paradox in epithelial growth. (Abstract). Invest. Ophth. Vis. Sci. 34 (Suppl.), S1302.
75. Lauweryns, B., van den Oord, J. J., De Vos, R. and Missotten, L. (1993) A new epithelial cell type in the human cornea. Invest. Ophthalmol. Vis. Sci. 34, 1983-1990.
76. Lauweryns, B., van den Oord, J. J. and Missotten, L. (1993) The transitional zone between limbus and peripheral cornea: an immunohistochemical study. Invest. Ophthalmol. Vis. Sci. 34, 1991-1999.
77. Waring, G. O., Roth, A. M. and Ekins, M. B. (1984) Clinical and pathologic description of 17 cases of corneal intraepithelial neoplasia. Am. J. Ophthalmol. 97, 547-59.
78. Jakobiec, S. A. (1988) Corneal tumors. In The Cornea (Eds. Kaufman, H. E., Barron, B. A., McDonald, M. B. and Waltman, S. R.). Pp. 563-598. Churchill, Livingstone, London.
79. Weinberg, R. A. (1989) Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49, 3713-3721.
80. Harvey, D. M. and Levine, A. J. (1991) P53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5, 2375-2385.
81. Vogt, P. K. (1993) Cancer genes. West. J. Med. 158, 273-278.
82. Dolmetsch, A. M., Alcocer, C. E., Scull, J. J., Martins, M. C., Stockl, F. A. and Burnier, M. N. (1996) The presence of human papilloma virus in pterygia. (Abstract). Invest. Ophthalmol. Vis. Sci. 37 (Suppl.), S43.
83. McDonnell, J. M., McDonnell, P. J. and Sun, Y.-Y. (1992) Human papilloma virus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest. Ophthalmol. Vis. Sci. 33, 184-189.
84. Coroneo, M. T. (1993) Pterygium as an early indicator of ultraviolet insolation: a hypothesis. Br. J. Ophthalmol. 77, 734-739.
85. Chen, J. K., Tsai, R. J. F. and Lin, S. S. (1994) Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell. Devel. Biol. Anim. 30A, 243-248.
86. Kim, Y. J., Park, E. S., Park, S. C. and Kim, J. C. (1994) Glutathione-S-Transferase (-pi,-2) and transglutaminase (TF-C) expression in pterygia. Invest. Ophthalmol. Vis. Sci. 35 (Suppl.), 1796.
87. Xu, G.-X., Tong, Y. and Lin, F.-S. (1995) Pathological study of pterygium. (Abstract). Invest. Ophthalmol. Vis. Sci. 36 (Suppl.), S1027.
88. Spencer, W. H. (1985) Ophthalmic Pathology: An Atlas and Textbook. 3rd ed. P. 176. Saunders, Philadelphia, PA.